Regen Biopharma issues 54.5M shares to retire $180,552 convertible note with Coventry

Regen BioPharma Inc

Issued 54,514,492 common shares to Coventry Enterprises LLC to satisfy $180,552 of convertible indebtedness.
Principal and accrued interest on $1.5M promissory note now $0 as of July 19, 2022.
Shares issued under Section 4(a)(2) exemption; no underwriter or commission paid.
Significant dilution for existing shareholders; all outstanding convertible debt now retired.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.